It is manufactured by Novo Nordisk, the pharmaceutical company behind a recent trial assessing the potential of a next-generation drug, CagriSema
BPC-157: The Tissue Repair Catalyst Derived from : Body Protection Compound found in gastric juice Mechanism : Promotes angiogenesis (formation of new blood vessels) Enhances fibroblast migration and growth Improves collagen formation Reduces inflammatory cytokines (e.g., TNF-alpha, IL-6) Impact : Accelerates healing in tendons, ligaments, muscles, nerves, and the GI tract TB-500: The Mobility Enhancer Synthetic version of : Thymosin Beta-4 Mechanism : Increases actin production (a protein essential for cell movement and structure) Promotes wound remodeling Reduces fibrosis and scar tissue Downregulates NF-kB , a key driver of inflammation Impact : Enhances cellular repair, improves mobility, reduces joint stiffness GHK-Cu: The Skin and Anti-Aging Powerhouse Naturally found in : Human plasma, saliva, and urine Mechanism : Binds to copper and delivers it into tissues Stimulates type I and III collagen production Increases elastin , glycosaminoglycans , and keratinocyte migration Acts as an antioxidant and anti-inflammatory compound Impact : Promotes firm, elastic skin
Cell protection and regeneration BPC 157 can activate intracellular repair signaling pathways (such as Akt and ERK), promoting cell proliferation and migration
Proper handling: Peptide storage matters
Cold-chain integrity: Temperature-controlled shipping and storage across the whole fulfilment chain
